BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 9, 2015
View Archived Issues
Urine-based prostate cancer diagnostic may help avoid unnecessary biopsies
Read More
Ferritin and IL-8 associated with clear cell renal carcinoma outcome
Read More
Bacteriolytic therapy feasible in advanced sarcoma patients
Read More
Malin plans to float on the ESM of Irish stock exchange to fund acquisitions and investments
Read More
FDA fast tracks AXS-02 for pain associated with complex regional pain syndrome
Read More
EMD Serono presents data from phase I study of MSC-2363318A
Read More
Ironwood Pharmaceuticals begins phase I study of IW-1973
Read More
TG Therapeutics and Checkpoint Therapeutics to develop immuno-oncology targeted antibodies
Read More
AOP Orphan completes enrollment in phase III trial of ropeginterferon alfa 2b
Read More
Phase III trial of VSV-EBOV for Ebola launching in Guinea
Read More
Eisai and Merck & Co. collaborate to study combination therapies in cancer
Read More
Baxter acquires SuppreMol
Read More
Tekmira completes merger with OnCore to create hepatitis B solutions company
Read More
FDA approves biosimilar product Zarxio
Read More
MAASTRO discloses dual action carbonic anhydrase inhibitors
Read More
Medshine Discovery patents DGAT-1 inhibitors
Read More
BioMmune reports in vivo progress in restoring immune recognition in cancer
Read More
U.S. scientists present novel and specific CYP26A1 inhibitors
Read More
Takeda reports development of lysophosphatidic acid receptor antagonists
Read More
Studies advance darunavir/cobicistat/emtricitabine/tenofovir alafenamide single tablet formulation
Read More
Merck & Co. describes new PAR-1 antagonists
Read More
FDA places hold on enrollment in ENDO trial of EndoBarrier
Read More
FDA approves Cresemba for invasive aspergillosis and invasive mucormycosis
Read More
Meiji Seika Pharma initiates phase III Japanese study of ziprasidone
Read More
Biogen Idec Japan launches long-acting agent for hemophilia A in Japan
Read More